✦ LIBER ✦

PCN13 COST-BENEFIT ANALYSIS OF A 21-GENE RECURRENCE SCORE FOR EARLY STAGE BREAST CANCER IN SINGAPORE

✍ Scribed by de Lima Lopes, G; Chien, R; Hornberger, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P215A Cost–benefit analysis of a 21-gene

✍ G. de Lima Lopes; R. Chien; J.C. Hornberger 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

PCN158 TREATMENT DECISION CHANGE WITH 21

✍ R Chien; J Hornberger 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Cost-effectiveness of a 21-gene recurren

✍ Malek B Hannouf, Bin Xie, Muriel Brackstone, Gregory S Zaric 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 314 KB

PCN21 COST-EFFECTIVENESS ANALYSIS OF ADJ

✍ Lee, HJ; Lee, TJ; Yang, BM 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Cost Effectiveness of a 21-Gene Recurren

✍ Hannouf, Malek B.; Xie, Bin; Brackstone, Muriel; Zaric, Gregory S. 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 442 KB

PCN55 THE IMPACT OF 21-GENE RT-PCRASSAY

✍ A Hammerman; SH Klang; N Liebermann; N Efrat 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB